Connection
James Falko to Glucose
This is a "connection" page, showing publications James Falko has written about Glucose.
|
|
Connection Strength |
|
 |
|
 |
|
0.101 |
|
|
|
-
Osei K, O'Dorisio TM, Falko JM. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. Am J Med. 1984 Dec; 77(6):1002-9.
Score: 0.042
-
Falko JM, Crockett SE, Cataland S, O'Dorisio TM, Kramer W, Mazzaferri EL. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man. Clin Endocrinol (Oxf). 1980 Dec; 13(6):587-93.
Score: 0.032
-
Osei K, Falko JM, O'Dorisio TM, Adam DR. Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care. 1985 Sep-Oct; 8(5):436-9.
Score: 0.011
-
Falko JM, Reynolds JC, O'Dorisio TM, Bossetti B, Cataland S. The role of gastric inhibitory polypeptide in the augmented insulin response to sucrose. Diabetes Care. 1982 Jul-Aug; 5(4):379-85.
Score: 0.009
-
Osei K, Falko JM, O'Dorisio TM, Fields PG, Bossetti B. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients. J Clin Endocrinol Metab. 1986 Feb; 62(2):325-30.
Score: 0.003
-
Osei K, Falko JM, O'Dorisio TM, Adam DR. Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care. 1984 Sep-Oct; 7(5):471-5.
Score: 0.003
-
Crockett SE, Cataland S, Falko JM, Mazzaferri EL. The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects. J Clin Endocrinol Metab. 1976 Jun; 42(6):1098-103.
Score: 0.001
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|